Evaluating the cost-effectiveness of artemisinin-based combination antimalarial drugs and malaria rapid diagnostic tests within the context of effective vector control : case study of Southern Africa

This study seeks to use the techniques of cost-effectiveness analysis to evaluate, within the context of effective vector control, the change to artemisinin-based combination therapies (ACTs) as first line malaria treatment and to evaluate the relevance of using definitive diagnosis (as opposed to clinical diagnosis) as the basis for initiating malaria treatment, especially when using ACTs for treatment. The cost-effectiveness of ACTs was evaluated in two study sites (i.e. In Kwazulu Natal which switched from SP monotherapy to AL in 2001 and in Mpumalanga which changed from SP monotherapy to AS+SP in 2003) in South Africa. The economic evaluation of use of routine definitive diagnosis as part of malaria case management, using rapid diagnostic tests (ROTs), was undertaken at two districts (Namaacha and Matutuine), in southern Mozambique, where routine use of ROTs and treating malaria patients with an ACT (using artesunate + SP) were implemented at pilot level in 2003.

Grantor dc:publisher.institution

Department of Public Health and Family Medicine

Year dc:date.issued

2006

Author dc:creator

• Zikusooka, Charlotte Muheki

Advisors dc:contributor.advisor

• McIntyre, Di
• Barnes, Karen

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/11427/7439

OAI identifier oai:identifier

oai:open.uct.ac.za:11427/7439